GLPwatch
⌘K
Drugs
▾
Ozempic
Wegovy
Mounjaro
Zepbound
Rybelsus
Trulicity
All drugs →
Molecules
▾
Semaglutide
Tirzepatide
Retatrutide
Orforglipron
All molecules →
News
Drugs
Molecules
News
Conditions
(19)
Approved indications (6)
Cardiovascular risk reduction
4 drugs approved · 1284 papers
Chronic kidney disease
1 drug approved · 588 papers
MASH (metabolic dysfunction-associated steatohepatitis)
0 drugs approved · 555 papers
Obesity
3 drugs approved · 3105 papers
Obstructive sleep apnea
1 drug approved · 101 papers
Type 2 diabetes
10 drugs approved · 5221 papers
Investigational / off-label (13)
Alcohol use disorder
0 drugs approved · 76 papers
Alzheimer's disease
0 drugs approved · 280 papers
Anxiety
0 drugs approved · 92 papers
Bipolar disorder
0 drugs approved · 31 papers
Depression
0 drugs approved · 150 papers
Fertility ("Ozempic babies")
0 drugs approved · 62 papers
Gastroparesis
0 drugs approved · 43 papers
Hair loss
0 drugs approved · 16 papers
Heart failure (HFpEF)
0 drugs approved · 395 papers
Opioid use disorder
0 drugs approved · 33 papers
Parkinson's disease
0 drugs approved · 127 papers
Polycystic ovary syndrome
0 drugs approved · 147 papers
Smoking cessation
0 drugs approved · 23 papers